Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 235 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for... August 27, 2025 AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading February 12, 2026 Urine test for bladder cancer being developed July 2, 2021 Epigenetic Changes Pinpointed as the Cause of Some GISTs November 19, 2019 Load more HOT NEWS FDA Approves Durvalumab for Locally Advanced or Metastatic Biliary Tract Cancer EMA Recommends Granting a Marketing Authorisation for Elacestrant Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού; Five Questions With…Jessica, Katie, and Melanie